Management of Post-Transplant Hyperparathyroidism and Bone Disease

Drugs - United Kingdom
doi 10.1007/s40265-019-01074-4
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Management of Post-Transplant Lymphoproliferative Disorders

British Journal of Haematology
Hematology
2018English

Post-Transplant Lymphoproliferative Disease – PTLD

2012English

Management of Epstein-Barr Virus-Induced Post-Transplant Lymphoproliferative Disease in Recipients of Solid Organ Transplantation

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2001English

Hyperparathyroidism of Renal Disease

Permanente journal,The
Medicine
2016English

Data-Driven Management of Post-Transplant Medications: An APOMDP Approach

SSRN Electronic Journal
2017English

Surgical and Medical Management of Tertiary Hyperparathyroidism

World Journal of Endocrine Surgery
Nuclear MedicineRadiologyEndocrinologyImagingSurgeryMetabolismDiabetes
2010English

Retrospective Review of Bone Mineral Metabolism Management in End-Stage Renal Disease Patients Wait-Listed for Renal Transplant

Transplant Research and Risk Management
TransplantationUncertaintyStatisticsProbability
2012English

Post Transplant Anaemia

2011English

Differences in Post-Transplant Hepatocellular Carcinoma Recurrence by Etiology of Liver Disease

Liver Transplantation
HepatologyTransplantationSurgery
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy